BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19121627)

  • 1. Improvement of adaptive immunity by antigen-carrying biodegradable nanoparticles.
    Uto T; Wang X; Akagi T; Zenkyu R; Akashi M; Baba M
    Biochem Biophys Res Commun; 2009 Feb; 379(2):600-4. PubMed ID: 19121627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of innate and adaptive immunity by biodegradable nanoparticles.
    Uto T; Akagi T; Hamasaki T; Akashi M; Baba M
    Immunol Lett; 2009 Jun; 125(1):46-52. PubMed ID: 19505507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120.
    Wang X; Uto T; Akagi T; Akashi M; Baba M
    J Virol; 2007 Sep; 81(18):10009-16. PubMed ID: 17609261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity of biodegradable nanoparticles with aluminum adjuvants: antigen uptake by dendritic cells and induction of immune response in mice.
    Uto T; Akagi T; Toyama M; Nishi Y; Shima F; Akashi M; Baba M
    Immunol Lett; 2011 Oct; 140(1-2):36-43. PubMed ID: 21693134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity.
    Matsuo K; Koizumi H; Akashi M; Nakagawa S; Fujita T; Yamamoto A; Okada N
    J Control Release; 2011 Jun; 152(2):310-6. PubMed ID: 21402114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
    Wang X; Uto T; Akagi T; Akashi M; Baba M
    J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells.
    Yoshikawa T; Okada N; Oda A; Matsuo K; Matsuo K; Kayamuro H; Ishii Y; Yoshinaga T; Akagi T; Akashi M; Nakagawa S
    Vaccine; 2008 Mar; 26(10):1303-13. PubMed ID: 18255205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway.
    Uto T; Akagi T; Yoshinaga K; Toyama M; Akashi M; Baba M
    Biomaterials; 2011 Aug; 32(22):5206-12. PubMed ID: 21492934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of gene expression related to Toll-like receptor signaling in dendritic cells by poly(gamma-glutamic acid) nanoparticles.
    Hamasaki T; Uto T; Akagi T; Akashi M; Baba M
    Clin Vaccine Immunol; 2010 May; 17(5):748-56. PubMed ID: 20219877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(γ-glutamic acid) nanoparticles.
    Shima F; Akagi T; Uto T; Akashi M
    Biomaterials; 2013 Dec; 34(37):9709-16. PubMed ID: 24016848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
    Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient generation of antigen-specific cellular immunity by vaccination with poly(gamma-glutamic acid) nanoparticles entrapping endoplasmic reticulum-targeted peptides.
    Matsuo K; Yoshikawa T; Oda A; Akagi T; Akashi M; Mukai Y; Yoshioka Y; Okada N; Nakagawa S
    Biochem Biophys Res Commun; 2007 Nov; 362(4):1069-72. PubMed ID: 17822676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice.
    Okamoto S; Matsuura M; Akagi T; Akashi M; Tanimoto T; Ishikawa T; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2009 Sep; 27(42):5896-905. PubMed ID: 19647814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Hydrophobic Side Chains in the Induction of Immune Responses by Nanoparticle Adjuvants Consisting of Amphiphilic Poly(γ-glutamic acid).
    Shima F; Akagi T; Akashi M
    Bioconjug Chem; 2015 May; 26(5):890-8. PubMed ID: 25865284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of potent adaptive immunity by the novel polyion complex nanoparticles.
    Uto T; Akagi T; Akashi M; Baba M
    Clin Vaccine Immunol; 2015 May; 22(5):578-85. PubMed ID: 25809631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus.
    Okamoto S; Yoshii H; Ishikawa T; Akagi T; Akashi M; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2008 Jan; 26(5):589-94. PubMed ID: 18180081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity.
    Uto T; Wang X; Sato K; Haraguchi M; Akagi T; Akashi M; Baba M
    J Immunol; 2007 Mar; 178(5):2979-86. PubMed ID: 17312143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives.
    Akagi T; Wang X; Uto T; Baba M; Akashi M
    Biomaterials; 2007 Aug; 28(23):3427-36. PubMed ID: 17482261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic stimulation of antigen presenting cells via TLR by combining CpG ODN and poly(γ-glutamic acid)-based nanoparticles as vaccine adjuvants.
    Shima F; Uto T; Akagi T; Akashi M
    Bioconjug Chem; 2013 Jun; 24(6):926-33. PubMed ID: 23631730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antigen-specific cytotoxic T lymphocytes by immunization with negatively charged soluble antigen through scavenger receptor-mediated delivery.
    Yamasaki Y; Ikenaga T; Otsuki T; Nishikawa M; Takakura Y
    Vaccine; 2007 Jan; 25(1):85-91. PubMed ID: 16956699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.